These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 13879359

  • 1. A proposed mechanism of action of 1-beta-D-arabinofuranosyl-cytosine as an inhibitor of the growth of leukemic cells.
    CHU MY, FISCHER GA.
    Biochem Pharmacol; 1962 Jun; 11():423-30. PubMed ID: 13879359
    [No Abstract] [Full Text] [Related]

  • 2. COMPARATIVE STUDIES OF LEUKEMIC CELLS SENSITIVE AND RESISTANT TO CYTOSINE ARABINOSIDE.
    CHU MY, FISCHER GA.
    Biochem Pharmacol; 1965 Mar; 14():333-41. PubMed ID: 14314330
    [No Abstract] [Full Text] [Related]

  • 3. OETTGEN HF, REPPERT JA, COLEY V: Studies on the synergism of fluorinated pyrimidines and certain pyrimidine and purine derivatives against transplanted mouse leukemia.
    BURCHENAL JH.
    Cancer Chemother Rep; 1960 Feb; 6():1-5. PubMed ID: 13806003
    [No Abstract] [Full Text] [Related]

  • 4. THE REVERSAL OF CYTOSINE ARABINOSIDE ACTIVITY IN VIVO BY DEOXYCYTIDINE.
    EVANS JS, MENGEL GD.
    Biochem Pharmacol; 1964 Jul; 13():989-94. PubMed ID: 14201141
    [No Abstract] [Full Text] [Related]

  • 5. SYNERGISM OF THE ANTINEOPLASTIC ACTIVITY OF CYTOSINE ARABINOSIDE BY PORFIROMYCIN.
    EVANS JS, BOSTWICK L, MENGEL GD.
    Biochem Pharmacol; 1964 Jul; 13():983-8. PubMed ID: 14201140
    [No Abstract] [Full Text] [Related]

  • 6. Comparative activity of 1-beta-d-arabinofuranosyl-5-fluorocytosine and related compounds against transplanted mouse leukemias in vivo and in vitro.
    Burchenal JH, Adams HH, Newell NS, Fox JJ.
    Cancer Res; 1966 Mar; 26(3):370-3. PubMed ID: 5930685
    [No Abstract] [Full Text] [Related]

  • 7. Nucleosides and nucleotides. 100. 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosyl-cytosine (CNDAC): design of a potential mechanism-based DNA-strand-breaking antineoplastic nucleoside.
    Matsuda A, Nakajima Y, Azuma A, Tanaka M, Sasaki T.
    J Med Chem; 1991 Sep; 34(9):2917-9. PubMed ID: 1895307
    [No Abstract] [Full Text] [Related]

  • 8. A comparative study of the antitumor and antiviral activity of 1-beta-D-arabinofuranosyl-5-fluorocytosine (FCA) and 1-beta-D-arabinofuranosylcytosine (CA).
    Prince HN, Grunberg E, Buck M, Cleeland R.
    Proc Soc Exp Biol Med; 1969 Apr; 130(4):1080-6. PubMed ID: 4305347
    [No Abstract] [Full Text] [Related]

  • 9. The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y).
    Chu MY, Fischer GA.
    Biochem Pharmacol; 1968 May; 17(5):753-67. PubMed ID: 5689802
    [No Abstract] [Full Text] [Related]

  • 10. ACTIVITY OF SELECTED COMPOUNDS IN SUBLINE OF LEUKEMIA L1210 RESISTANT TO CYTOSINE ARABINOSIDE (NSC-63878).
    WODINSKY I, KENSLER CJ.
    Cancer Chemother Rep; 1964 Dec; 43():1-3. PubMed ID: 14250647
    [No Abstract] [Full Text] [Related]

  • 11. Inhibition of the growth of mouse leukemia cells in culture by 5-iododeoxyuridine.
    MATHIAS AP, FISCHER GA, PRUSOFF WH.
    Biochim Biophys Acta; 1959 Dec; 36():560-1. PubMed ID: 14422291
    [No Abstract] [Full Text] [Related]

  • 12. Comparative studies on the in vivo action of 6-chloropurine, 6-chloropurine ribonucleoside, and 6-chloro-9-ethylpurine on sarcoma 180 ascites cells.
    SARTORELLI AC, BOOTH BA.
    J Pharmacol Exp Ther; 1961 Oct; 134():123-8. PubMed ID: 14497281
    [No Abstract] [Full Text] [Related]

  • 13. Clinical pharmacology of 1-beta-d-arabinofuranosyl cytosine.
    Ho DH, Frei E.
    Clin Pharmacol Ther; 1971 Oct; 12(6):944-54. PubMed ID: 5289712
    [No Abstract] [Full Text] [Related]

  • 14. Nucleic acids. II. Cytotoxicity studies with nucleotides and dinucleoside phosphates containing ara-cytidine.
    Smith CG, Buskirk HH, Lummis WL.
    J Med Chem; 1967 Sep; 10(5):774-6. PubMed ID: 6048482
    [No Abstract] [Full Text] [Related]

  • 15. Studies on the biochemical pharmacology of 5-iodo-2'-deoxycytidine in vitro and in vivo.
    CRAMER JW, PRUSOFF WH, WELCH AD, SARTORELLIAC, DELAMORE IW, VON ESSEN CF, CHANG PK.
    Biochem Pharmacol; 1962 Aug; 11():761-8. PubMed ID: 13881995
    [No Abstract] [Full Text] [Related]

  • 16. Experimental evaluation of potential anticancer agents. IX. The ribonucleosides and ribonucleotides of two purine antagonists.
    MONTGOMERY JA, SCHABEL FM, SKIPPER HE.
    Cancer Res; 1962 May; 22():504-9. PubMed ID: 14475543
    [No Abstract] [Full Text] [Related]

  • 17. Arabinosyl-6-mercaptopurine and arabinosyl-6-mercaptopurine-5'-phosphate: comparison of their metabolic effects.
    LePage GA, Bell JP, Wilson MJ.
    Proc Soc Exp Biol Med; 1969 Jul; 131(3):1038-41. PubMed ID: 5791773
    [No Abstract] [Full Text] [Related]

  • 18. Studies in the mouse of the pharmacology of 5-iododeoxyuridine, an analogue of thymidine.
    PRUSOFF WH, JAFFE JJ, GUNTHER H.
    Biochem Pharmacol; 1960 May; 3():110-21. PubMed ID: 14435159
    [No Abstract] [Full Text] [Related]

  • 19. Summary of current information on 6-azauridine.
    HANDSCHUMACHER RE, CALABRESI P, WELCH AD, BONO V, FALLON H, FREI E.
    Cancer Chemother Rep; 1962 Aug; 21():1-18. PubMed ID: 13904321
    [No Abstract] [Full Text] [Related]

  • 20. A synopsis of recent investigations of 5-iodo-2'-deoxyuridine.
    WELCH AD, PRUSOFF WH.
    Cancer Chemother Rep; 1960 Feb; 6():29-36. PubMed ID: 13843820
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.